![Nathalie Dubois-Stringfellow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 48 324 $ al 30/09/2026
Nathalie Dubois-Stringfellow has held roles at XOMA (US) LLC as Senior Director- Alliance Management and at Sangamo Therapeutics, Inc. as Chief Development Officer.
Both positions are current.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/05/2026 | 328.733 ( 0,08 % ) | 48 324 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2019 |
XOMA (US) LLC
 XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
